Insmed's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Insmed, Inc. (INSM)

Q2 2012 Earnings Call

August 07, 2012 8:30 am ET


Brian Ritchie – Investor Relations, FTI Consulting

Timothy G. Whitten – President, Chief Executive Officer and Director


Christopher N. Marai – Wedbush Securities, Inc.



Good day ladies and gentlemen, and welcome to the Second Quarter 2012 Insmed Incorporated Earnings Conference Call. My name is Jeanine and I’ll be operator for today. At this time, all participants are in listen-only mode. Later we will conduct a question-and-answer session. (Operator Instructions) As a reminder this conference is being recorded for replay purposes.

I would now like to turn the conference over to Mr. Brian Ritchie, FTI Consulting. Please proceed, sir.

Brian Ritchie

Thank you, operator. Good morning everyone. This is Brian Ritchie from FTI Consulting, and welcome to Insmed’s second quarter 2012 conference call. Insmed issued a press release this morning containing second quarter 2012 financial results, which is posted on the company’s website. Today, we are joined by Mr. Tim Whitten, President and CEO, who will provide a business update and review the financials. Following the prepared remarks, Tim will be available for a question-and-answer session. We would ask you to please limit yourself to one question and one follow-up, so we have time for as many questions as possible.

Before we proceed with the call, I would like to remind everyone that the Safe Harbor language contained in today’s press release also pertains to this conference call and webcast.

Please go ahead, Tim.

Timothy G. Whitten

Thank you, Brian. Hello everyone and thank you for joining us on today’s second quarter 2012 conference call.

If you liked this article you might like

North Korea Gives Wall Street Rude Awakening After Labor Day Break

Dow Tanks, Fear Gauge Spikes as United Tech Slumps, North Korea Rattles Nerves

North Korea Threat Roars Back Into Focus and Wall Street Retreats

Stock Futures Decline Amid Rising North Korea Tensions

Health Sector Down As Report of Industry Price Collusion Surfaces